Company / PP&E per Share
Bio-Rad Laboratories PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$18.48
FY2025
5-year range
$16.53 / $18.48
FY2021-FY2025
Trend
+4.3%
vs FY2024
Sector context
#18 of 128
Health Care
What the data says
Bio-Rad Laboratories's pp&e per share of $18.48 is higher than 86% of companies in the Health Care sector (FY2025). PP&E per Share has increased for 3 consecutive years, from $16.53 in FY2022 to $18.48 in FY2025.
Based on SEC 10-K filings.
18.48 in FY2025 with a 5-year CAGR of +2.6%. Top quartile in the Health Care sector.
Improved from $17.51 to $18.48 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +3.8%
- 5-Year CAGR
- +2.6%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 128This company $18.48 Sector average $11.86
▼
+55.9% above sector average
Key checks
Key Insights
- Bio-Rad Laboratories's pp&e per share has grown for 3 consecutive years.
- In FY2025, pp&e per share increased 4.3% year-over-year.
- Ranks #18 out of 128 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2020.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.48 | +4.3% |
| FY2024 | $17.73 | +1.2% |
| FY2023 | $17.51 | +5.9% |
| FY2022 | $16.53 | -2.5% |
| FY2021 | $16.95 | +4.3% |
| FY2020 | $16.26 | -2.2% |
| FY2019 | $16.63 | -3.1% |
| FY2018 | $17.16 | +2.3% |
| FY2017 | $16.78 | +0.1% |
| FY2016 | $16.77 | +10.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026